FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.

Rupp M, Hagenbuchner J, Rass B, Fiegl H, Kiechl-Kohlendorfer U, Obexer P, Ausserlechner MJ

Open source

DOI
10.1038/onc.2017.288
Published
2017 Nov 2
Container
Oncogene
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/onc.2017.288,
  title = {FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.},
  author = {Rupp M and Hagenbuchner J and Rass B and Fiegl H and Kiechl-Kohlendorfer U and Obexer P and Ausserlechner MJ},
  year = {2017},
  journal = {Oncogene},
  doi = {10.1038/onc.2017.288},
  url = {https://doi.org/10.1038/onc.2017.288}
}

RIS

TY  - JOUR
TI  - FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.
AU  - Rupp M
AU  - Hagenbuchner J
AU  - Rass B
AU  - Fiegl H
AU  - Kiechl-Kohlendorfer U
AU  - Obexer P
AU  - Ausserlechner MJ
PY  - 2017
JO  - Oncogene
DO  - 10.1038/onc.2017.288
UR  - https://doi.org/10.1038/onc.2017.288
ER  - 

APA

M, R., J, H., B, R., H, F., U, K., P, O., & MJ, A. (2017). FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.. Oncogene. https://doi.org/10.1038/onc.2017.288

Source records